ENDRA Life Sciences Inc.
NDRA· Nasdaq
NDRAENDRA Life Sciences Inc.
Filed Jun 21, 2017 · 10-Q · 82 days after period end · 0001654954-17-005768
| Metric | Q1 2017 | Q1 2016 |
|---|---|---|
| Revenue | $0.00 | — |
| Net Income | -$741.62K | -$379.48K |
| EPS Diluted | -$1.03 | -$0.52 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ENDRA Life Sciences Inc. · CIK 1681682 · Engraved from SEC EDGAR
ended Mar 31, 2017 · filed Jun 21, 2017 · 82 d after period end
